Background 26
10
Neisseria belongs to the family Neisseriaceae and colonizes the mucosal surfaces of 154 animals and contains a few known pathogenic species [27] . 155
We next compared neighboring groups along the disease progression, i.e. Control 156 versus I_III and I_III versus DM, in order to identify biomarker species for specific disease 157 stages. We found that the Cardiobacterium was again identified to be enrichened in 158
Control as compared with I_III ( Figure 3B ). In addition, we found a few biomarker species 159 that were uniquely enriched in DM as compared with I_III, including three genera from the 160 family Coriobacteriaceae (such as Atopobium, Eggerthella, and Olsenella). 161 Coriobacteriaceae is a group of gram-positive bacteria that are often nonmotile, 162 nonspore-forming, nonhemolytic and strictly anaerobic [28] . They are normal dwellers of 163 mammalian body habitats including the oral cavity [29] , the gastrointestinal tract [30] , and 164 the genital tract [31] . Consistent to our results, several members of the genera, including 165 Atopobium, Eggerthella, Gordonibacter, Olsenella, and Paraeggerthella had been 166 implicated in the development of various clinical pathologies including abscesses [32] , 167 periodontitis [33] , intestinal diseases and tumors [34, 35] . Surprisingly, we found two 168 genera of the family Coriobacteriaceae were identified as gut-biomarkers ( Figure 3C ). For 169 example, genus Olsenella was also enriched in fecal samples of the I_III group as compared 170 with the controls, while genus Eggerthella was also enriched the DM group as compared gut-microbial biomarkers were shared; the overlapping could be due to either extensive 173 transmission from oral to other body sites [24] , or the exposure to the same environment. 174
175
The contributions of sputum and fecal microbiotas in patient stratification 176 We next assessed the potential value of sputum and gut microbiota in patient stratification. 177
We generated predictive models using the Random forest algorithm implemented in 178
Siamcat [36] , evaluated the model performance with 10-times cross-validation and 179 reported the averaged area under receiving operating characteristics curves values 180 (AUROCs or AUC for short; see Methods) from 1000 repeats. We first generated models 181 using the sputum and gut microbiota separately (referred to as sputum-and gut-models 182 respectively). As shown in Figure 4A -D and Table 2 , we found that sputum microbiota 183 performed better than gut in patient stratification, in all subject group comparisons ( Table  184 2). 185
We then built predictive models using both the sputum and fecal microbiome data as 186 input (referred to as mixed models below). Among the enrolled subjects, we identified in 187 total 91 subjects who had both sputum and fecal samples, among which 26, 27 and 38 188 were healthy controls, stage I_III and DM patients respectively. As shown in Figure 4A -D 189
and Table 2 , we found that the mixed model could perform either slightly better than or 190 comparable to that of the sputum (Table 2) . 191
We then examined the top twenty genera ranked according to their importance to the 192 mixed models. As shown in Figure 4 & Supplementary Figure 2 , there were more 193 sputum-derived genera than gut-derived genera in numbers. For example, only seven and 194 three gut-derived genera were among the top twenty in the Control versus NSCLC (Figure 195 4D) and Control versus I_III ( Figure 4E ) models, respectively. More importantly, the 196 sputum-derived genera in general ranked higher in the mixed models and had higher 197 cumulative importance scores (Table 3) . 198
Together, these results suggested that the sputum microbiota contributed more than 199 the gut microbiota in patient stratification. In most cases, the sputum microbiota alone 200
was sufficient for decent model performance. 201
202
Top ranking taxa were also significantly shared by the sputum-and fecal-203 machine-learning models 204 We next checked if there were significant overlap in the top-ranking taxa between 205 sputum-and fecal-models between controls and NSCLC; shared taxa often indicated that 206 they may play similar roles at different body sites. As shown in Figure 5A -B, we found four 207 of the top genera were shared at the same time in Control vs. NSCLC and Control vs. I_III 208 models, including Macellibacteroides, Streptococcus, Clostridium and Bacteroides. when retained in the gut, but when they escaped this environment they could cause 211 significant pathology, including bacteremia and abscess formation in multiple body sites 212
[37]. Clostridium were associated with a range of human diseases [38] , and currently under 213 investigation and testing as antitumor agents, because they germinated only in hypoxic 214 tissues (i.e., tumor tissue), allowing precise targeting and direct killing of tumor cells [39] . 215
Five out of twenty genera (Anaerosinus, Clostridium, Bacteroides, Actinomyces and 216 Streptococcus) were shared by sputum and gut models of I_III vs. DM ( Figure 5C ). The
217
human digestive tract was the main habitat for Anaerosinus [37] . There were several types We also checked the overlapping of the top-ranking taxa in models between 222 neighboring disease stages, such as models for Control vs. I_III and I_III vs. DM. Again, we 223 found even more shared taxa. For example, we found seventeen out of the top twenty 224 genera were shared in the two models generated using individual microbiota ( Figure 5E-F) . 225
Unlike the sputum with more variety genera, there were two main families in gut, 226 Ruminococcaceae and Lachnospiraceae; most members of which were found in human or 227 animal digestive tract [41] . Previous studies have noted that both of them were depleted in 228 patients with cirrhosis [42], enriched during alcohol abstinence and inversely correlated 229 with intestinal permeability [43, 44] . These bacteria were known to have a beneficial effect 230 on gut barrier function [44] . Not surprisingly, we found that in the mixed models, in which 231 the same taxa from sputum-and fecal-were treated as distinct features, several of the 232 above-mentioned taxa from both sputum and feces were among the top twenty taxa, 233
including Streptococcus in the Control vs. NSCLC models, Anaerosinus, Bacteroides and 234 Streptococcus in the I_III vs. DM models. Together, these results indicated that the same 235 set of microbial taxa were underlying the development and progression of NSCLC, and the 236 biomarkers for DM might be acquired early. 237
238
Pseudomonas aeruginosa, a species implicated in infections, was enriched 239 in brain-metastatic patients Figure 6A , left panel). As shown in Figure 6A , in the sputum 245 microbiota, we found significantly different beta-diversities (P=0.011; middle panel) 246 between the two groups, while there was no significant difference in fecal microbiota 247 (P=0.178; right panel). Thus, the dysbiosis of sputum microbiota was in stronger 248 association with brain metastasis of NSCLC than fecal. We next performed LEfSe analysis 249 and Wilcoxon rank-sum test to identify potential microbial biomarkers between BM and 250 nonBM groups ( Figure 6B -C). Several differentially abundant genera were identified, 251
including Pseudomonas, Actinomyces in sputum and Blautia and Pseudomonas in feces.
252
Pseudomonas was highly abundant in the sputum of the BM group (~8.14%) but not 253 detectable in the nonBM group with relative abundance close to zero ( Figure 6B We then generated the distinguishing BM and nonBM models using the sputum 258 microbiota, gut microbiota and mixed microbiota separately. As shown in Figure 7A , we 259 found that sputum microbiota performed best in BM and nonBM group comparison. We 260 also examined the top-ranking taxa in sputum-, fecal-and mixed models. As shown in 261
Supplementary Figure 3 , there were more sputum-derived genera than gut-derived 262 genera in numbers. Only three gut-derived genera were among the top twenty in the BM 263 versus nonBM mixed model. Again, we found Pseudomonas was the most important 264 genus to sputum-and mixed models between BM and nonBM ( Figure 7B and 265 Supplementary figure 3). Thus, Pseudomonas is a prominent biomarker for brain 266 metastasis in sputum. Pseudomonas consists of a groups of aerobic, Gram-negative and their prevalence and abundances in gut microbiota associated with human health and 270 diseases [45] 
Discussion

279
We believed that the present study is the first to investigate the alterations of both sputum 280 (as a proxy for lung) and gut microbiota on the development and metastasis of NSCLC. 281
The results of our study suggest that lung microbiota may play major roles in the 282 development of NSCLC, the dysbiosis of which could accurately stratify patients from 283 healthy controls, while the distant metastasis (DM) was associated with both sputum and 284 gut microbiota dysbiosis. We further identified a prominent microbial biomarker for brain 285 metastasis (BM). 286
In recent years, growing evidence have linked the alterations in lung or gut microbiota 287 to LC or NSCLC. However, the relative importance of the gut and lung microbiota to the 288 development of NSCLC are still unclear; in addition, their alterations along with DM of 289 NSCLC have not been characterized. Therefore, in this study we assembled a cohort 290 including patients of diagnosed NSCLC, including those suffered from DM (stage IV), and 291 collected both sputum and fecal samples. We delineated the microbial community 292 structure by 16S rRNA sequencing. The sputum and gut microbiota differed significantly in 293 terms of alpha-diversity and beta-diversity, regardless health statuses and disease stages; 294 surprisingly, sputum microbiota had significantly higher richness (taxon count) and 295 evenness than gut microbiota, suggesting unappreciated microbial complexity in the 296 respiratory systems and putative important roles in related diseases. We built machine 297 learning models to evaluate the relative importance of sputum and gut microbiota in 298 patient stratification. We found that both sputum and gut microbiota dysbiosis 299 contributed significantly to discriminating metastatic to non-metastatic patients, while 300 sputum microbiota performed the best in discriminating stage I_III patients from healthy 301 controls. These results highlighted the potentials using both sputum and gut microbiota in 302 non-invasive disease diagnosis. 303
By comparing to healthy controls of matching demographic and clinical characteristics, 304
we identified microbial biomarkers that showed significant abundance differences 305 between subject groups. Not surprisingly, many of the identified biomarkers were either 306 previously associated with other diseases [38, 40] , or known to induce inflammation 307 and/or interact with host immunity [31] [32] [33] [34] [35] [36] [37] [38] . For example, the genera Atopobium, Eggerthella and Olsenell ( Figure 3C ,F), belong to the family Coriobacteriaceae, had been 309 implicated in the development of various clinical pathologies including abscesses [32] , 310 periodontitis [33], intestinal diseases and tumors [34, 35] ; and that Atopobium was the 311 third important genus to I_III vs IV mixed model ( Figure 4F ). Similarly, a genus Filifactor, 312 which was the most important genus in the Control vs NSCLC mixed model, was 313 significantly enriched in NSCLC patients; it was known that some species of Filifactor were 314 members of human oral microbiome and were pathogenic [21] . 315
We found significant overlap between sputum-and fecal-biomarkers, suggesting that 316 these microbes may play similar roles at different body sites. In addition, most of the 317 microbial-biomarkers of distinct disease stages, i.e. I_III vs. healthy controls and DM vs. I_III, 318 also overlapped ( Figure 5 ); we found that the cumulative abundances of these biomarkers 319 were increased (decreased) continuously along disease development. These results 320 suggested that distant metastasis (DM) was the ultimatum development of lung cancer, 321 and the DM-modulating microbes were acquired early. 322
We identified Pseudomonas aeruginosa as a prominent biomarker for brain 323 metastasis (BM); P. aeruginosa was highly abundant in BM patients as compared with 324 other NSCLC as well as other distant metastatic patients and was exclusively found in 325 sputum. P. aeruginosa is found in many diseases and is often associated with long-term Despite the strengths of our study, there were two limitations. First, currently only 328 limited numbers of subjects were enrolled, which could limit the predictive performance of 329 our patient stratification models; better ML models would have been possible with more 330 subjects and deeper coverage of metagenomics sequencing data. Second, the exact roles 331 of gut and lung microbiota in NSCLC and metastasis needed to be further illustrated. In summary, we surveyed both sputum (as a proxy for lung) and gut microbiota of patients 337 with NSCLC and distant metastasis and compared them with healthy controls. We 338 obtained mathematical models capable of distinguishing patients from healthy controls as 339 well as patients at different disease stages with high performance. The top taxa ranked by 340 these models could be used for future experiments to illustrate the underlying molecular 341 mechanisms, and/or biomarkers for disease diagnosis. Our analyses revealed that the 342 alterations of sputum (as a proxy to lung) microbiota have stronger association with 343 NSCLC and distant metastasis than the gut, indicating that tumor-site associated 344 microbiota may contribute more to disease development. 
Methods
Sequencing data analysis and taxonomic assignment 387
Overall read quality was checked for each sample using FastQC. After Trimmomatic, reads 388 with quality less than 30 or length less than 100 bp were removed from subsequent 389 analysis. The filtered reads were then analyzed using Qiime2 (version 2018.11) [49] . DADA2 390 software, wrapped in QIIME2, was used to filter the sequencing reads and construct 391 feature table. The taxonomy classify database was downloaded from Qiime2 392 (gg-13-8-99-515-806-nb-classifier.qza). Taxa with relative abundance less than 0.001 was 393 removed. All analyses were carried out on genus level except for the alpha diversity. The 394 taxonomy classify on species level was identified using "MAPseq" [46] , which is a highly 395 efficient approach with confidence estimates, for reference-based rRNA analysis; while 396 also providing more accurate taxonomy classifications. 397
Statistics analysis
using SPSS V.19.0 for Windows (Statistical Product and Service Solutions, Chicago, Illinois, 401 USA). 402
The beta diversity analyses were performed using the R package "Vegan". Principal Conversely, applying similar analyses to fecal samples, no alpha-diversities (C) but the 645 beta-diversity in I_III compared with DM (D) was significantly different, suggesting that 646 fecal microbiota dysbiosis was associated with distal metastasis, but not NSCLC. was significantly different between NSCLC and control group in sputum (left) and fecal 652 (right), respectively. In order to identify biomarker for specific disease stages, we 653 compared neighboring groups along the disease progression in sputum (B) and fecal (C). 654
Control versus I_III, left; I_III versus DM, right. Stage Ⅰ-Ⅲ
Stage Ⅰ-Ⅲ
vs Stage Ⅳ n = 29 n = 30 n = 55
Healthy vs
vs Stage Ⅳ 
